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S64Objective: In the present study, we determined the safety and efficacy of robotic mitral valve replacement using
robotic technology.
Methods: From January 2007 through March 2011, more than 400 patients underwent various types of robotic
cardiac surgery in our department. Of these, 22 consecutive patients underwent robotically assisted mitral valve
replacement. Of the 22 patients with isolated rheumatic mitral valve stenosis (9 men and 13 women), the mean
age was 44.7  19.8 years (range, 32–65). Preoperatively, all patients underwent a complete workup, including
coronary angiography and transthoracic echocardiography. Of the 22 patients, 15 had concomitant atrial fibril-
lation. The surgical approach was through 4 right-side chest ports with femoral perfusion. Aortic occlusion was
performed with a Chitwood crossclamp, and antegrade cardioplegia was administered directly by way of the
anterior chest. Using 3 port incisions in the right side of the chest and a 2.5- to 3.0-cm working port, all the
procedures were completed with the da Vinci S robot.
Results: All patients underwent successful robotic surgery. Of the 22 patients, 16 received a mechanical valve
and 6 a tissue valve. The mean cardiopulmonary bypass time and aortic crossclamp time was 137.1 21.9 min-
utes (range, 105–168) and 99.3  17.9 minutes (range, 80–133), respectively. No operative deaths, stroke, or
other complications occurred, and no incisional conversions were required. After surgery, all the patients
were followed up echocardiographically.
Conclusions: Robotically assisted mitral valve replacement can be performed safely in patients with isolated
mitral valve stenosis, and surgical results are excellent. (J Thorac Cardiovasc Surg 2012;143:S64-7)Minimally invasive cardiac surgery has emerged as an inter-
esting alternative for a wide variety of surgical procedures.
Less-invasive valve surgery has proved even more promis-
ing than less-invasive coronary bypass procedures because
simpler anastomoses are required. The feasibility and safety
of robotic mitral valve replacement (MVR) has been proven
in several studies,1-3 with the main goals of improved cosm-
esis and less postoperative discomfort while maintaining
the same level of safety and efficacy as with conventional
surgery. However, robotically assisted MVR demands dif-
ferent surgical skills in the implant of the prosthesis. When-
ever introducing a new technique, it is necessary to
determine the incremental risk to the patient compared
with the benefit achieved. Few data have been published
concerning the outcomes of robotically assisted MVR.4e Minimally Invasive and Robotic Cardiac Surgery Center, Department of
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The Journal of Thoracic and Cardiovascular SurgWe report the early results for the first 22 consecutive
patients who underwent robotically assisted MVR.METHODS
Patients
From January 2007 through March 2011, more than 400 patients under-
went various types of robotic cardiac surgery in our department. Of these
patients, 22 consecutive patients underwent robotically assisted MVR.
The institutional review board approved the present study, and the 22
patients provided informed consent. Of the 22 patients with isolated rheu-
matic mitral valve stenosis (9 men and 13 women), the mean age was 44.7
 19.8 years (range, 32–65). Preoperatively, all patients underwent a com-
plete workup, including coronary angiography and transthoracic echocar-
diography. All 22 patients had good left ventricular function. The
preoperative characteristics are listed in the Table 1. Two patients were
in New York Heart Association class I, 16 in class II, and 4 in class III;
15 patients had concomitant atrial fibrillation (Table 1).
Surgical Technique
After induction of general anesthesia, all patients were intubated for
single-lung ventilation, and a transesophogeal echocardiography (TEE)
probe and arterial pressure monitoring line were inserted. Both a central
catheter and a 15F venous drainage cannula were placed percutaneously
into the right internal jugular vein. External defibrillator patches were
paced to subtend the maximum cardiac mass. Each patient was positioned
with the right side of the chest elevated approximately 30 and with right
arm tucked at the side. After systemic heparinization, femoral arterial
(18F or 20F) and venous (21F or 23F) cannulation (Metronic, Minneapolis,
Minn) were performed through a 2-cm transverse right groin incision cut-
down with the Seldinger guidewire method and TEE guidance. Bicaval
venous drainage was instituted through the jugular and femoral/inferior
vena cava cannulas.ery c April 2012
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ICS ¼ intercostal space
MVR ¼ mitral valve replacement
TEE ¼ transesophogeal echocardiographyFIGURE 1. da Vinci setup for mitral valve replacement. Every stitch was
fixed sequentially outside with a small hemostat.The camera cannula was placed in the right side, 2 to 3 cm lateral to the
nipple in the fourth intercostal space (ICS). A 2.5- to 3.0-cm incision was
used as a working port in the same ICS for the patient-side surgeon. The
soft tissue retractor was inserted into this port, and no other rib retractor
was used (Figure 1). The da Vinci instrument arms were inserted through
three 0.8-cm trocar incisions in the right side of the chest. The right instru-
ment arm was generally poisoned lateral to the working port in the sixth
ICS. The left instrument arm was positioned medially and cephalad to
the working port in the second ICS. The fourth trocar arm was placed in
the midclavicular line in the fifth ICS. All resection and suturing of the
mitral valve and atrial closure were completed with the da Vinci S robot.
Cardiopulmonary bypass was initiated with kinetically assisted bicaval
venous drainage. The aorta was occluded with a Chitwood crossclamp
(Scanlan International, Minneapolis, Minn) using the midaxillary line in
the fourth ICS. Antegrade cold blood cardioplegic solution was adminis-
tered directly through the anterior chest (second ICS) with a 14F angiocath-
eter, by which de-airing was conducted, and repeat doses could be given
when necessary. TEE was used routinely to monitor the position of the an-
giocatheter and assist with de-airing. Carbon dioxide was insufflated con-
tinuously into the operative field for air displacement. The left atrium was
then opened parallel to the interatrial septum. All MVRs were performed
using standard techniques. The diseased mitral valve was completely
excised, and the posterior leaflets were preserved whenever possible. Ap-
propriate sizing was performed, and everting, double-armed, mattress
sutures with Teflon pledgets were placed counterclockwise from the
11-o’clock position. Every stitchwas fixed sequentially outsidewith a small
hemostat. Usually 10 to 12 sutures were needed (Figure 1). Once the su-
tures were placed in the prosthesis sewing ring outside the chest, the pros-
thesis was lowered into the chest and positioned, and the knots were tied
using the knot pusher through the incision (Figure 2). The atriotomy was
closed with 4-0 polytetrafluoroethylene running suture (W. L. Gore & As-
sociates, Flagstaff, Ariz). Before the Chitwood crossclamp was released,
meticulous intracardiac de-airing was conducted through the angiocatheter
of cardioplegia, and then the aorta was unclamped. The patient was weaned
from cardiopulmonary bypass, and the cardioplegia site was closed with anBLE 1. Patient characteristics (n ¼ 22)
Characteristic Value
e (yr)
ean 44.7  9.8
ange 32–65
der (n)
ale 9 (35)
emale 13 (65)
an ejection fraction (%) 50.2  13.8
York Heart Association class
2 (10)
I 14 (70)
II 4 (20)
us rhythm (n) 5 (25)
ial fibrillation (n) 15 (28)
a in parentheses are percentages.
The Journal of Thoracic and Carextracorporeal knot tied through the working port, and chest tubes were
inserted. The prosthesis function was confirmed by TEE.
The data are shown as the mean standard error of the mean (Figures 1
and 2).RESULTS
All patients underwent successful robotically assisted
MVR. Of the 22 patients, 16 received a mechanical valve
(St Jude Medical, St Paul, Minn) and 6 received a biopros-
thetic valve (Cosgrove-Edwards; Edwards Lifesciences,
Irvine, Calif), and all patients recovered uneventfully. The
mean cardiopulmonary bypass time and aortic crossclamp
time was 137.1  21.9 minutes (range, 105–168) and 99.3
 17.9 minutes (range, 80–133), respectively. As shown
in Figure 2, both the crossclamp and bypass times decreased
significantly with experience. Intraoperative TEE revealed
appropriate prosthesis function in all patients. One patient
had effusion in the right hemithorax. The mean intensiveFIGURE 2. The mechanical valve is set into the right position and tied
through the working port.
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Technical Considerations Gao et alcare unit stay was 1.5 days (range, 1–3). In the entire series,
no device-related complications, stroke, peripheral ische-
mic event, or operative deaths occurred, and no incisional
conversions were required. After surgery, all patients were
followed up echocardiographically, and no patient had a par-
avalvular leak. The mean follow-up time was 12.1  6.6
months (Figure 3).DISCUSSION
The most common surgical approach to the mitral valve
requires the surgeon to saw open the breastbone and spread
the edges apart to gain direct access to the heart. Although
this approach provides excellent access to the heart, the re-
sulting wound requires several months to heal completely,
resulting in an extended recovery period with substantial
activity restrictions, and can be subject to serious complica-
tions, including infection, breakdown, and even death. In
contrast, robotic cardiac surgery can extend the ability of
the surgeons, performing MVR using a 3-cm working
port without rib resection and retraction, toward new chal-
lenges, albeit with the potential danger of performing sub-
optimal surgery because of the learning curve issue.
After more than 400 cases of various types of robotic car-
diac surgery,5-9 we believe that the da Vinci Surgical system
can be considered the best surgical solution to the philo-
sophic approach of minimally invasive cardiac surgery.
The 3-dimensional digital vision system enables natural
depth perception with high-power magnification (103). A
perfect view was obtained of all cardiac chambers, the
mitral valve, and the subvalvular apparatus, especially in
patients with a small left atrium.
Although many reports have described the excellent re-
sults of robotically assisted mitral valve repair using the daFIGURE 3. The learning curve for the crossclamp time of robotic mitral
valve replacement (learning curve for crossclamp time: y (min)¼ 132.757
17.82 ln (x); r2 ¼ 0.718; P<.01).
S66 The Journal of Thoracic and Cardiovascular SurgVinci Surgical system,1-3 few data are available on roboti-
cally assisted MVR.4 All our patients had satisfactory
clinical outcomes, as demonstrated by the complete echocar-
diographic follow-up. No late thromboembolic complica-
tions or paravalvular leaks developed. Intraoperative
contamination must be considered when performing extra-
thoracic knots and introducing the prosthetic ring through
the narrow working port, although no cases of either native
or prosthetic mitral valve endocarditis were identified during
follow-up in our patients.
The suture techniques for robotic MVR are very different
from those in the open technique. For all mechanical and
bioprosthetic valves, we used everting, double-armed mat-
tress sutures with Teflon pledgets counterclockwise from
the 11-o’clock position to prevent any possibility of suban-
nular obstruction of the valve leaflets by protruding tissue
and to prevent 1 suture from crossing with another. Every
stitch was fixed sequentially outside with a small hemostat.
Usually 10 to 12 sutures were needed (Figure 1). Once the
sutures were placed sequentially in the prosthesis sewing
ring outside the chest, the prosthesis was lowered into the
chest and positioned, and the knots were tied with the
knot pusher through the incision. When the knots are tied
with the knot pusher, the console surgeon must confirm
the knot tightness 1 by 1, and in the case of a knot not being
tight, the knot tightness requires robotic assistance. Re-
cently, we started using the Cor-Knot (LSI Solution, Victor,
NY) to tie the knots during robotic MVR. This has resulted
in a shorter operative time, and the preliminary results have
been satisfactory.
It is believed that any new surgical approach requires
a learning curve, and robotic cardiac surgery is no excep-
tion. We believe that robotic cardiac surgery requires real
teamwork and surgeons must overcome a substantial learn-
ing curve. Our leaning curve is showed graphically in
Figure 3. The mean crossclamp time was significantly
shortened with surgical experience as denoted by the num-
ber of operations. Our learning curve was truncated because
the console surgeon simultaneously performed a large vol-
ume of various types of other robotic cardiac surgeries with
the same team within a relative short period. Furthermore,
since we started our robotic surgical program, our robotic
team has not changed. Our experience has demonstrated
that with a well-trained robotic team and after a substantial
learning curve, optimal results can be achieved with robotic
surgery.5-9
In conclusion, the present results suggest that robotically
assisted MVR for patients with isolated mitral valve steno-
sis is safe. The 3-dimensional digital vision system provides
a perfect view of the mitral valve and the subvalvular appa-
ratus in patients in whom limited exposure prohibits direct
vision. This method also provides the unique opportunity to
observe experienced surgeons at work, shortening the learn-
ing curve and avoiding mistakes.ery c April 2012
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